ÂÜÀòÂÒÂ×

Matt Harlow is a highly skilled scientist with extensive experience in oncology and cancer biology. Currently serving as a Senior Scientist at TRIANA Biomedicines since February 2024, Matt has previously held positions as Scientist II at Civetta Therapeutics from October 2021 to September 2023 and as a Postdoctoral Fellow at Dana-Farber Cancer Institute from September 2017 to October 2021. Educationally, Matt earned a PhD in Oncology and Cancer Biology from Vanderbilt University School of Medicine, where studies were completed from 2011 to 2017, following a Bachelor of Science degree in Biology from the University of North Carolina at Chapel Hill from 2005 to 2009.